Literature DB >> 2506023

Ciprofloxacin resistance in methicillin- and gentamicin-resistant Staphylococcus aureus.

P Maple1, J Hamilton-Miller, W Brumfitt.   

Abstract

A total of 112 Staphylococcus aureus strains resistant to methicillin and gentamicin were collected from 31 centres in 22 countries worldwide. Many strains were multi-resistant. In tests to determine the susceptibility of the organisms to ciprofloxacin 16 strains (14.3%), originating from France, the FRG, Israel and Italy, were shown to be resistant to this agent. To limit ciprofloxacin resistance, a reappraisal is necessary of fluoroquinolone usage against methicillin- and gentamicin-resistant Staphylococcus aureus.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2506023     DOI： 10.1007/bf01968141

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  8 in total

1.  World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.

Authors:  P A Maple; J M Hamilton-Miller; W Brumfitt
Journal:  Lancet       Date:  1989-03-11       Impact factor: 79.321

2.  Ciprofloxacin resistance in epidemic methicillin-resistant Staphylococcus aureus.

Authors: 
Journal:  Lancet       Date:  1988-10-08       Impact factor: 79.321

3.  [Course of the resistance of Staphylococcus aureus to pefloxacin. A study based on 782 strains isolated in 1985 and 1986].

Authors:  H Jean-Pierre; G Boyer; A Jean; H Darbas
Journal:  Pathol Biol (Paris)       Date:  1988-10

4.  Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization.

Authors:  M E Mulligan; P J Ruane; L Johnston; P Wong; J P Wheelock; K MacDonald; J F Reinhardt; C C Johnson; B Statner; I Blomquist
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

5.  Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.

Authors:  S M Smith; R H Eng
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

6.  Autobac susceptibility testing of methicillin-resistant Staphylococcus aureus isolated in an Australian hospital.

Authors:  R A Putland; M D Guinness
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

7.  The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus.

Authors:  S M Smith; R H Eng; E Berman
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

8.  Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.

Authors:  S Schaefler
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948
  8 in total
  8 in total

Review 1.  The emergence of antibiotic resistance: myths and facts in clinical practice.

Authors:  J M Hamilton-Miller
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Epidemiological markers for epidemic strain and carrier isolates in an outbreak of nosocomial oxacillin-resistant Staphylococcus aureus.

Authors:  A Bouvet; J M Fournier; A Audurier; C Branger; A Orsoni; C Girard
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.

Authors:  J C Lucet; M Herrmann; P Rohner; R Auckenthaler; F A Waldvogel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Increasing resistance of Staphylococcus aureus to ciprofloxacin.

Authors:  T E Daum; D R Schaberg; M S Terpenning; W S Sottile; C A Kauffman
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

5.  Occurrence of quinolone resistance in Staphylococcus aureus from nosocomial infection.

Authors:  W Witte; H Grimm
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

6.  Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.

Authors:  P A Maple; J M Hamilton-Miller; W Brumfitt
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

7.  Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

Authors:  Neeta D Gade; Mohiuddin S Qazi
Journal:  J Lab Physicians       Date:  2013-07

8.  The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.

Authors:  Najwa A Mhmoud; Ahmed Hassan Fahal; El Sheikh Mahgoub; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2014-06-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.